Pharma Secretary urges closer cooperation between India, Japan in pharma, med devices sector Read more
Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate Read more
COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate Read more